Risk of lung cancer diagnosis among patients receiving cardiac CT scan is significantly higher than that of the general population, however, most of these patients did not qualify for LCS.
Abstract
Background
Lung cancer screening (LCS) rates are low despite expanded eligibility criteria. Many patients receiving cardiac CT scans may also have risk factors for lung cancer. We aimed to identify an opportunity to increase LCS by quantifying this population.
Methods
All patients in our healthcare system from January 2011 to December 2023 who received a CT heart or CT angiogram heart were included. Lung cancer rates in this population were assessed. LCS eligibility was determined by USPSTF guidelines.
Results
A total of 31,684 patients received cardiac CT scans and 17,232 patients met the study criteria (documented smoking history, age 50-80 years, no prior diagnosis of lung cancer). Based on 2021 USPSTF guidelines, 114 (0.7%) patients were eligible for LCS compared to 0.37% of all patients in our healthcare system. A total of 73 patients undergoing cardiac CT developed a diagnosis of lung cancer. Among those meeting LCS eligibility, 1 (0.8%) developed lung cancer, 7 (6.1%) received a low dose CT, and 21 (18.4%) received a diagnostic chest CT. An additional 72 (0.4%) patients of patients who received a cardiac CT were subsequently diagnosed with lung cancer at a median of 19.8 (5.7, 51.7) months, yet did not meet LCS eligibility.
Conclusions
Risk of lung cancer diagnosis among patients receiving cardiac CT scan is significantly higher than that of the general population. However, most of these patients did not qualify for LCS. Advocacy for more complete chest imaging in this population may facilitate identification of lung cancer for early intervention.
INTRODUCTION
Identification of populations eligible for lung cancer screening (LCS) is a priority question in this field. The primary objective of this study was to quantify lung cancer prevalence after a first round of LCS among patients with history of atheromatous cardiovascular disease (aCVD) and tobacco exposure....
Elsa Armand, C. Buton, Caroline Caramella et al.· Respiratory medical research· 0 citations
Individuals with rheumatoid arthritis (RA), particularly those with a history of smoking, are at increased risk for lung cancer. However, real-world data on the use of low dose computed tomography (LDCT) screening for lung cancer in this population are lacking. Therefore, we assessed the rates, trends, and predictors o...
M. Lopez-Olivo, Zhi-Gang Duan, Hui-Fang Lu et al.· Cancer Prevention Research· 0 citations
Among US adults with lung cancer, approximately half were screening-eligible, and only one-third underwent screening before diagnosis, highlighting gaps in both eligibility and utilization.
Izabella Zanazanian, Angela Y Chieh, Aarushi Madan et al.· Cancer Causes and Control· 0 citations
OBJECTIVE
Patients with peripheral arterial disease (PAD) present a high risk of cancer-related mortality. We aimed to evaluate a screening approach combining low-dose thoracic computed tomography (LDCT) and circulating tumor cell (CTC) search for cancer detection in PAD patients.
DESIGN
A prospective multicenter coh...
Alexandra Yannoutsos, J. Pastre, D. Damotte et al.· Lung Cancer· 0 citations
A structured narrative review of PubMed, Embase, and the Cochrane Library for studies published between January 2002 and March 2026 supplemented by review of current clinical guidelines from the USPSTF, NCCN, ACS, CHEST, and ERS established the mortality benefit of low-dose computed tomography screening.
Arihant Surana, Riya Bhattacharya· Romanian Journal of Preventi...· 0 citations
PURPOSE
Lung cancer is the leading cause of cancer mortality in Jordan, with most cases presenting at advanced stages. Low-dose computed tomography (LDCT) screening has demonstrated mortality reduction in high-risk populations in developed countries. This study evaluates the feasibility and potential impact of implemen...
Mohannad Y. Al-Qatanany, A. Salem, D. Dahabreh et al.· JCO Global Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.